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Conserved roles of C. elegans and human MANFs
in sulfatide binding and cytoprotection
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Mesencephalic astrocyte-derived neurotrophic factor (MANF) is an endoplasmic reticulum
(ER) protein that can be secreted and protects dopamine neurons and cardiomyocytes from
ER stress and apoptosis. The mechanism of action of extracellular MANF has long been
elusive. From a genetic screen for mutants with abnormal ER stress response, we identified
the gene Y54G2A.23 as the evolutionarily conserved C. elegans MANF orthologue. We find
that MANF binds to the lipid sulfatide, also known as 3-O-sulfogalactosylceramide present in
serum and outer-cell membrane leaflets, directly in isolated forms and in reconstituted lipid
micelles. Sulfatide binding promotes cellular MANF uptake and cytoprotection from hypoxia-
induced cell death. Heightened ER stress responses of MANF-null C. elegans mutants and
mammalian cells are alleviated by human MANF in a sulfatide-dependent manner. Our
results demonstrate conserved roles of MANF in sulfatide binding and ER stress response,
supporting sulfatide as a long-sought lipid mediator of MANF’s cytoprotection.
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Oxidizing environment is essential for protein folding andfunctions in the endoplasmic reticulum (ER) of eukar-yotic cells1–3. The Ero1-PDI enzymatic cascade in the ER
mediates the oxygen-dependent disulfide bond formation and
proper folding of transmembrane or secreted proteins. Severe
hypoxia (reduced ambient oxygen), as frequently occurs in
ischemic and neoplastic disorders, causes cellular ER stress
response independently of the well-characterized hypoxia-indu-
cible factor (HIF) pathway4–6. Eukaryotic cells actively maintain
protein folding and redox homeostasis in the ER upon hypoxic
and oxidative stresses by regulating numerous cellular factors to
promote normal physiological functions and cytoprotection.
Among such factors that have been studied, mesencephalic
astrocyte-derived neurotrophic factor (MANF) is an enigmatic
family of proteins with rather unique mode and mechanisms of
action.
Mammalian MANF was initially identified for its neurotrophic
effects on dopaminergic neurons7. It is a 20 kDa small secreted
protein that exhibits no amino acid sequence similarities to any
other classical families of target-derived neurotrophic factors,
including glial cell-derived neurotrophic factor (GDNF)
and brain-derived neurotrophic factor (BDNF) . MANF family
proteins are highly evolutionarily conserved with both human
and Drosophila orthologues being capable of promoting dopa-
mine neuron survival8–10. Its N-terminus contains a structural
fold similar to Saposin proteins while its C-terminus contains a
SAP (SAF-A/B, Acinus, and PIAS) domain similar to that of
Ku70, an inhibitor of proapoptotic Bax11,12. MANF is widely
expressed in the body, with levels particularly high in the nervous
system, kidney, heart, and pancreatic β cells13–15. Cellular MANF
abundance and secretion are strongly up-regulated by ER stress-
related stimuli, including hypoxia, ischemia, chemical treatments
with tunicamycin or thapsigargin13,15–17. Because of its secretion
from cardiomyocyte and autocrine/paracrine effects on cardio-
vascular functions, MANF has been termed “cardiomyokine”
playing critical roles in cardioprotection, hypertrophy, and heart
failure18. MANF KO mice are diabetic with abnormal activation
of unfolded protein response in pancreatic islets, while its gain-of-
function by exogenous MANF addition, physiological up-reg-
ulation, or transgenic MANF overexpression has been shown to
protect dopaminergic neurons, cerebral neurons, Purkinje cells,
retinal neurons, pancreatic β cells, and cardiomyocytes from
degeneration or cell death7,8,13,19–22.
Despite potent cytoprotective effects and emerging therapeutic
potentials of MANF for neurodegenerative, cardiovascular, dia-
betic, and ischemic disorders, how extracellular MANF signals to
cells and confers cytoprotection has remained largely elusive. No
MANF receptor has been identified despite over a decade of
research since its cytoprotective activity was discovered in 2003.
Although it has been suggested that MANF might bind to certain
cell surface lipids via its N-terminal Saposin-like domain, the
molecular identity of MANF-binding lipids and how its potential
lipid-binding ability might contribute to cytoprotection are
unknown. Understanding the mechanisms of action of extra-
cellular MANF in cytoprotection thus remains a key challenge of
the field.
In this work, we started with a C. elegans genetic screen and
identified an uncharacterized C. elegans orthologue of MANF as
a regulator of the ER stress response. In a lipid biochemical
screen, we discovered sulfatide as a direct interactor of both C.
elegans and human MANFs. Sulfatide is a sulfoglycolipid syn-
thesized in ER and Golgi, distributed to the extracellular leaflet
of many cell types, and can be released to extracellular space
and circulation in mammals23,24. By characterizing C. elegans
and human MANFs in lipid binding and roles in protecting
from ER stress and cell death, we provide multiple lines of
evidence that MANF confers cytoprotection, at least in part,
through direct binding to sulfatide and subsequent uptake by
both C. elegans and mammalian cells.
Results
A genetic screen identifies a C. elegans manf-1 mutant. We
sought to identify new regulators of HIF-independent ER stress
response by performing forward genetic screens for C. elegans
mutants with abnormal ER stress responses. The C. elegans gene
hsp-4 encodes the orthologue of human ER chaperone BiP and is
a well-established ER stress-inducible gene25–28. By random
mutagenesis of the C. elegans transgenic strain in which GFP
reporter expression is driven by the hsp-4 promoter, we isolated
mutants with constitutive GFP expression even without externally
induced ER or hypoxic stresses. One mutation dma1 caused fully
recessive, completely penetrant, and strong constitutive activation
of hsp-4p::GFP, predominantly in the intestine and pharyngeal
epithelium of C. elegans (Fig. 1a). We genetically mapped the
mutation dma1 by single-nucleotide polymorphism-based linkage
analysis and molecularly identified the causal gene (Supplemen-
tary Fig. 1). Based on RNA interference (RNAi) phenocopy of the
dma1 mutant and its transformation rescue with transgenic
arrays of wide-type alleles, we determined that dma1 defines a
previously uncharacterized gene Y54G2A.23, which encodes the
sole orthologue of the highly evolutionarily conserved MANF
protein family (Fig. 1b, c, Supplementary Fig. 1). CRISPR-
mediated deletions of Y54G2A.23 caused constitutively high levels
of hsp-4p::GFP with phenotype identical to that of dma1 (Fig. 1c).
We found that hsp-4p::GFP expression caused by dma1 was
suppressed by RNAi against xbp-1 or ire-1, which encodes an ER
stress sensor and activator of the ER stress-responding tran-
scription factor XBP-1 (Fig. 1c). The mutation dma1 as confirmed
by Sanger sequencing is a missense transition mutation that
converts serine 75 to leucine at the N-terminus of MANF-1
(named for Y54G2A.23; Fig. 1b, Supplementary Fig. 1d and 2).
C. elegans manf-1 is widely expressed in several major tissues,
including intestine, hypoderm, spermatheca, and nervous
systems, based on an integrated transcriptional reporter in
which GFP is driven by the endogenous manf-1 promoter
(Fig. 1d). The constitutive expression of hsp-4p::GFP in
intestinal cells of dma1 mutants was fully rescued by expression
of manf-1(+) driven by the intestine-specific ges-1 promoter, the
ubiquitously active rpl-28 promoter or a transgenic array
expressing human MANF driven by the C. elegans manf-1
promoter (Fig. 1e, f). By contrast, a mutant manf-1(C146G)
carrying the substitution of an invariant cysteine C146
completely conserved in the MANF protein family failed to
rescue the constitutive hsp-4p::GFP expression of dma1 mutants
(Fig. 1e). In addition, we found that chronic (24 h) but not acute
(1 h) exposure of manf-1 mutants to tunicamycin, an ER stress-
inducing protein glycosylation inhibitor, decreased progeny
numbers to a larger degree in manf-1 mutants than wild type
(Supplemental Fig. 1e). These findings indicate that C. elegans
manf-1 plays an evolutionarily conserved role in regulating ER
stress responses.
Both C. elegans and human MANFs bind directly to sulfatide.
To explore novel mechanisms of MANF’s cytoprotection, we first
examined structural motifs of the hitherto uncharacterized C.
elegans MANF-1 (Ce-MANF). Based on homology-based struc-
tural modeling against the crystal structure of Hs-MANF29, Ce-
MANF contains a saposin-like fold at the N-terminus and a SAP-
like C-terminal domain (Supplementary Fig. 2a, b). Since Saposin
family proteins solubilize various sphingolipids for degradation in
lysosomes30, we tested the binding of purified Ce-MANF to an
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array of 16 structurally defined sphingolipids spotted on a
nitrocellulose membrane (Echelon sphingostrip lipid overlay
assay). We found that Ce-MANF binds specifically to one single
lipid species, corresponding to sulfatide (Fig. 2a). Purified Hs-
MANF also exhibited binding to sulfatide, prepared from either
bovine brains or synthetic sources (Fig. 2b, Supplementary
Fig. 2e). Using lipid overlay assays, we examined other lipids that
are structurally similar to sulfatide but otherwise lacking or with
variant chemical groups and found that both the acyl chain and
sulfate are essential for the binding (Fig. 2c). To determine
whether MANF can bind to sulfatide freely in solution we per-
formed size exclusion chromatography of micelle-reconstituted
(by Tween-20 and dodecyl maltoside detergents) Hs-MANF with
or without sulfatide. We observed association of Hs-MANF with
detergent micelles only when sulfatide was present (Fig. 2d, e). In
addition, sulfatide specifically deterred enzymatic digestion of Hs-
MANF by trypsin (Fig. 2f, Supplementary Fig. 3a, b) and pro-
tected Hs-MANF against thermal denaturation (Supplementary
Fig. 3c). These results identify sulfatide as a sulfated glycolipid
that directly binds to Ce-MANF and Hs-MANF.
Sulfatide binding mediates conserved cytoprotection of MANF.
Since MANF protein family members are highly evolutionarily
conserved (Supplementary Fig. 2c, f), we investigated whether
MANF binding by sulfatide might facilitate cytoprotection of
MANF in both C. elegans and mammalian cells.
In C. elegans, we found that the constitutively high expression
level of hsp-4::GFP in manf-1 mutants can be fully rescued by
transgenic arrays expressing either wild-type C. elegans manf-1 or
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Fig. 1 A genetic screen identifies C. elegans manf-1 in regulating hsp-4p::GFP. a Exemplar GFP fluorescence and Nomarski images showing constitutive
activation of hsp-4p::GFP in the dma1 mutant isolated from mutagenesis screens. Wild type and mutant L4-stage animals (indicated by arrows) are aligned
in the same field to compare GFP intensity at low (above) or high (bottom) magnification. Scale bars, 100 µM. b Schematic of manf-1 gene structure with
various manf-1 alleles and extrachromosomal arrays (Ex) indicated. c Summary table for the hsp-4p::GFP phenotype of the wild type compared with various
mutants, with indicated levels of GFP intensity in the intestine, the major site of hsp-4p::GFP expression, and penetrance (N≥ 100 for each genotype). d
Integrated manf-1p::Venus transcriptional reporter indicating the widespread expression of manf-1. e Exemplar GFP fluorescence images showing the rescue
of the hsp-4p::GFP phenotype in the manf-1 null tm3603 mutant by C. elegans manf-1(+) and human MANF driven by the manf-1 promoter. Transgenic
rescuing arrays are marked by unc-54p::mCherry expressed in body wall muscles. f Summary table showing the rescuing effect of various transgenes on hsp-
4p::GFP of the manf-1(tm3603) mutant with indicated GFP intensity levels and penetrance (N≥ 100 for each genotype)
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human MANF (Fig. 1c, e, f). We generated HEK293T lentiviral
stable cell lines that constitutively express and secrete Hs-MANF,
which carries a C-terminal V5 epitope for tagging and to minimize
ER retention31. Using the secreted Hs-MANF collected from cell
culture media, we found thatmanf-1 null C. elegansmutants can be
partly rescued by incubation with exogenous Hs-MANF protein in
the presence of sulfatide in liquid culture (Fig. 3a–c). The reduction
of hsp-4::GFP levels was accompanied with increased levels of Hs-
MANF uptake in C. elegans manf-1 null mutants (Fig. 3c). The
uptake of Hs-MANF in C. elegans was mediated, at least in part, by
specific dynamin-dependent endocytosis machinery (Fig. 3d) in C.
elegans and was independent of epitope tagging, bacterial food
presence or stages of animals but dependent on presence of
sulfatide (Supplementary Figs. 3d and 5c). The uptaken Hs-MANF
appeared widely localized in C. elegans tissues (Fig. 3e). These
results indicate that Hs-MANF can by uptaken in a sulfatide-
dependent manner and rescue the ER stress response of manf-1
null mutants in C. elegans.
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Fig. 2 Purified MANF binds to sulfatide. a Lipid overlay assay with an Echelon Sphingostrip membrane showing specific binding of His-tagged Ce-MANF to
sulfatide. b Lipid overlay assay with customized lipid membrane showing dose-dependent binding of His-tagged Hs-MANF to sulfatide, prepared from
bovine brains or synthetic source. c Lipid overlay assay with customized lipid membrane spotted with sulfatide-related lipids showing that sulfate as well as
both acyl chains moieties are required for the sulfatide::Hs-MANF interaction. d Size exclusion chromatography with Hs-MANF reconstituted in 0.05%
Tween-20 and varying doses of sulfatide. Molar ratio of MANF:Sulfatide at 1:20 was sufficient for 50% fraction to be bound onto tween-sulfatide micelles
(peak at 6.99ml elution). e Size exclusion chromatography with Hs-MANF reconstituted in 1.5 mM dodecyl maltoside (DDM) and varying doses of
sulfatide. Molar ratio of MANF:Sulfatide at 1:100 resulted in 40% protein fraction to be bound onto DDM-sulfatide micelles (peak at 9.31 ml elution). f
Limited proteolysis using trypsin protease showing that Hs-MANF is protected against digestion upon sulfatide binding, under conditions of different
cleavage times (0, 1, and 10min) and MANF versus sulfatide molar ratios (1:10, 1:25, and 1:50)
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We next examined effects of MANF and sulfatide in cultured
mammalian cells. MANF::V5 from the conditioned medium of
the lentiviral stable line can bind to sulfatide (Fig. 4a) and
protect both HEK293T cells as well as the H9C2 cardiomyocyte
cell line after severe ER stress or hypoxia with glucose
deprivation conditions (Supplementary Fig. 4a–c). To probe
the specific role of sulfatide binding in conferring cytoprotec-
tion, we compared the effect of wild-type Hs-MANF with a
K112L mutant exhibiting reduced binding activity to sulfatide.
We found that sulfatide did not bind to the Hs-MANF
paralogue cerebral dopamine neurotrophic factor (CDNF)
(Supplementary Fig. 2e). The evolutionarily conserved surface
lysine residue K112 in Hs-MANF (K88 in crystal structure of
Hs-MANF, substituted with leucine in CDNF) partly accounts
for the difference between MANF and CDNF29. We found that
the MANF (K112L) mutant exhibited markedly reduced binding
to sulfatide, without affecting expression levels (Fig. 4a–c). The
K112L mutation attenuated the survival-promoting effect of Hs-
MANF in both HEK293T and H9C2 cells (Fig. 4d, e,
Supplementary Fig. 4c). Cytoprotective effects of Hs-MANF
was also blocked by the O4 monoclonal antibodies against
sulfatide, further demonstrating the essential role of endogenous
sulfatide for cytoprotection of Hs-MANF (Fig. 4d, e). These
results indicate that potent cytoprotective effects of Hs-MANF
are facilitated by specific binding to sulfatide.
Binding to sulfatide promotes cellular uptake of MANF. Given
the abundance of cell surface and extracellular sulfatide as well as
its known roles in membrane trafficking23,24, we hypothesize that
sulfatide facilitates MANF functions by promoting cellular uptake
of MANF both in C. elegans (Fig. 3c–e) and mammalian cells.
Indeed, we found that secreted wild type but not K112L mutant
Hs-MANF proteins from conditioned media were efficiently
uptaken by target HEK293T cells in a dose-dependent manner
(Fig. 5a, b). The uptaken Hs-MANF appeared to extensively co-
localize with the MANF-interacting protein GRP78 (i.e. the ER
resident chaperone BIP), indicating its likely endocytosis fol-
lowing cell surface binding (Fig. 5c). The uptake of wild-type Hs-
MANF can be further enhanced by exogenous sulfatide or
increased endogenous levels of sulfatide in target cells by over-
expressing the gene encoding the sulfatide-biosynthetic enzyme
cerebroside sulfotransferase (CST) (Fig. 5a, Supplementary
Fig. 5a). To test whether MANF might be endocytosed to pro-
mote the intracellular degradation of sulfatide, as the canonic
saposin-B protein does, we measured sulfatide levels in Hs-
MANF over-expressing and CRISPR-mediated KO cells and
found Hs-MANF does not affect sulfatide levels (Supplementary
Fig. 5b). As the V5-tagged MANF, the tag-free MANF was
similarly uptaken by target cells in a sulfatide-dependent manner
(Supplementary Fig. 5c). These results indicate that MANF binds
to sulfatide for efficient cellular endocytosis, not for degradation.
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Fig. 3 ER stress-rescuing effects of MANF and sulfatide in C. elegans. a Schematic of experimental workflow to test rescuing effects of human MANF from
conditioned cell culture PBS. b Exemplar GFP fluorescence images showing the rescue of the hsp-4p::GFP phenotype in the manf-1 null tm3603 mutant by
incubation with purified MANF secreted from conditioned media. MANF alone rescued only mildly compared with fuller rescue by MANF plus exogenous
sulfatide addition (500 µM in DMSO; sulfatide alone had no rescue), with indicated penetrance of rescue (N≥ 100 for each genotype). c Exemplar western
blot of Hs-MANF in C. elegans manf-1 mutants after incubating with Hs-MANF, showing sulfatide dependency of endocytosis and rescue of hsp-4::GFP
levels by endocytosed Hs-MANF. d Normalized levels of Hs-MANF::V5 immunoblot signals (from three biological replicates of N≥ 100 animals) showing
block of Hs-MANF endocytosis in temperature-sensitive endocytosis mutant dyn-1(ts) cultured from 25 °C but not at the permissive temperature, 20 °C. e
Exemplar immunofluorescence images of C. elegans tissues stained with anti-His (green) and DAPI (blue) indicating the uptaken His::MANF with sulfatide.
Scale bar, 15 µm
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We next characterized the role and mechanism of action of the
sulfatide-mediated enhancement of Hs-MANF endocytosis. Endo-
genous sulfatide is biosynthesized in ER and Golgi while MANF is
normally retained in the ER and up-regulated by ER stress and
hypoxia, followed by secretion and cellular release through the ER/
Golgi pathway16,19. We verified that severe hypoxia can indeed
drastically increase the abundance of Hs-MANF into the
extracellular medium while its secretion can be blocked by
brefeldin A, a classic inhibitor of the ER/Golgi secretion pathway
(Supplementary Fig. 6a, b). In addition, we found that the ratio of
bound/free MANF increases at pH 6.0 and 6.75 (Supplementary
Fig. 6c), characteristic of the Golgi lumen. These results suggest
that sulfatide is likely associated with MANF during its secretion
and facilitates the subsequent endocytosis of MANF to target cells.
To minimize the contribution from endogenous and other
sources of sulfatide present in the cell culture medium that
contains serum and thus sulfatide, we collected the secreted
Hs-MANF in phosphate-buffered saline (PBS) and found that
adding exogenous sulfatide to Hs-MANF in PBS markedly
increased Hs-MANF endocytosis in a dose- and time-
dependent manner (Supplementary Fig. 7a–c). Furthermore,
treatment with sulfatide antibodies or its degrading enzyme
sulfatase in the cell culture medium attenuated Hs-MANF
endocytosis (Supplementary Fig. 7a). To exclude the potential
involvement of other factors in the conditioned medium
indirectly affecting endocytosis, we purified Hs-MANF from
cell culture media using affinity antibodies against the V5
epitope in Hs-MANF and found that antibodies against
sulfatide inhibited endocytosis while exogenous sulfatide
drastically enhanced endocytosis (Supplementary Fig. 7b).
The enhancement of Hs-MANF endocytosis by sulfatide was
apparently specific since sulfatide exhibited no enhancing
effects on the endocytosis of another two distinct secreted
proteins (Supplementary Fig. 7d), and can be blocked by
inhibitors of endocytic machineries32 (Supplementary Fig. 7e).
These results provide further evidence that the sulfatide level is
a critical and specific determinant of Hs-MANF endocytosis.
MANF-sulfatide alleviates ER stress response in cultured cells.
C. elegans experiments clearly indicated the roles of both Ce-
MANF and Hs-MANF in alleviating ER stresses (Figs. 1 and 3).
To further examine whether MANF can alleviate ER stresses also
in mammalian cells, we monitored the formation of G3BP-
marked stress granules in U2OS cells33,34 evoked by thapsigargin
(Tg), an ER stress triggering inhibitor of mammalian sarco/
endoplasmic reticulum Ca²+-ATPase. We found that Tg induced
a time-dependent stress granule formation that were markedly
attenuated by pretreatment with Hs-MANF (Fig. 6a). Compared
with Hs-MANF, the Hs-MANF K112L mutant exhibited mark-
edly reduced ability to attenuate stress granule formation (Fig. 6b,
c). The effect of exogenous sulfatide manifested more promi-
nently with lower doses of Hs-MANF, suggesting that endogen-
ous sulfatide bound to Hs-MANF affected stress granule
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Fig. 4 Sulfatide binding is critical for cytoprotection by MANF in culture. a Lipid overlay assay showing secreted V5-tagged Hs-MANF and recombinant
His-tagged Hs-MANF bound to sulfatide (left), with secreted Hs-MANF::V5 confirmed by western blot of cell lysate and medium (right). HSP90 was used
as a loading control. b Size exclusion chromatography of wild-type Hs-MANF and K112L mutants reconstituted in 0.05% Tween-20 and sulfatide. Only
20% of the K112L mutant Hs-MANF was bound onto the micelle fraction compared with 50% of the wild-type Hs-MANF. c Lipid overlay assay (above)
showing that secreted MANF (K112L) from HEK293T cell lines exhibited markedly reduced binding to sulfatide with western blot (bottom) showing normal
protein levels in the HEK293T stable line. d Death rates of HEK293T cells after 48 h of 0.1% hypoxia with pretreatment of Hs-MANF or MANF (K112L)
mutant-conditioned media or with additional anti-sulfatide O4 antibodies. e Death rates of HEK293T cells after 24 h of indicated treatment followed by 40
h exposure to 0.5 µM thapsigargin (Tg). Error bars: S.E. with ***P < 0.001 (N≥ 3 independent biological replicates)
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formation (Fig. 6c). These results support the notion that
sulfatide-bound MANF alleviates ER stress responses also in
mammalian cells.
Discussion
The cytoprotective and ER stress-alleviating effects of MANF are
highly evolutionarily conserved8–10,13. In mammals, MANF has
been shown to be particularly effective in protecting dopamine
neurons, retinal ganglion cells, and cardiomyocytes against oxi-
dative and ER stresses8,16,19. However, molecular mechanisms of
how secreted MANF elicits cytoprotection have been undefined.
Our studies identify sulfatide as a lipid interactor of MANF and
the sulfatide-binding capacity is critical for cytoprotective effects
of MANF. We further demonstrate that sulfatide promotes cel-
lular uptake of MANF in both C. elegans and mammalian cells
and that C. elegans manf-1 mutants can be rescued by human
MANF, suggesting highly evolutionarily conserved mechanisms
by which MANF alleviates ER stress and cell toxicity under
hypoxic and ER stress conditions.
Both Ce-MANF and Hs-MANF contain saposin-like structural
folds at N-termini (Supplementary Fig. 2)13. Limited proteolysis
by trypsin digestion followed by mass spectrometry identified
predominantly the N-terminal part of Hs-MANF protected upon
sulfatide addition, suggesting that the N-terminal saposin-like
domain of MANF binds to sulfatide directly (Supplementary
Fig. 3a, b). Hypoxia, which lowers pH of the extracellular envir-
onment, promotes MANF secretion (Supplementary Fig. 6b) and
likely enhances cytoprotection against hypoxic toxicity. Several
other saposin-like proteins have been shown to bind to sphin-
golipids; in particular, saposin-B binds to and presents sulfatide
to arylsulfatase A for sulfatide degradation in the lysosome30.
Unlike saposin-B, however, MANF does not affect sulfatide levels
(Supplementary Fig. 5b). Our findings suggest that MANF retains
the sulfatide-binding capacity by the conserved saposin-like
structural fold and is molecularly chaperoned by sulfatide, rather
than presenting sulfatide for degradation, through the secretion
pathway and extracellular milieu to facilitate eventual cellular
uptake and cytoprotection in target cells.
Sulfatide-dependent cellular uptake of MANF also suggests a
previously unappreciated mechanism of its neurotrophic activity.
Based on collective evidence from C. elegans genetics, in vitro
lipid–protein biochemistry and mammalian cell culture model,
we propose that extracellular sulfatide-bound MANF enters the
cell through endocytosis and mediates cytoprotection by pro-
moting ER homeostasis and/or interacting with additional cyto-
protective effectors. Our endocytosis model can thus reconcile the
established effect of extracellular MANF and its reported intra-
cellular effect in cytoprotection, e.g. by direct binding and inhi-
bition of proapoptotic Bax family proteins11,12. Whether sulfatide
binding of MANF requires additional cell surface receptor(s) and
mechanisms how their interaction elicits intracellular signaling
events to mediate cytoprotection await further investigation.
Sulfatide is biosynthesized first in the ER where the ceramide
moiety is converted to galactocerebroside and subsequently sul-
fated to generate sulfatide by CST in the Golgi. Arylsulfatase A
(ARSA) is activated by saposin-B and degrades sulfatide in the
lysosome. Intriguingly, the C. elegans genome appears to encode a
homolog (sul-2) of ARSA but not CST. We speculate that C.
elegans might take sulfatide from its feeding bacteria to facilitate
MANF signaling, although it remains also possible that C. elegans
MANF relies on endogenous sulfatide-like lipids for trafficking
b
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Fig. 5 Sulfatide promotes cellular uptake of MANF. a Exemplar western blot of lysates from target HEK293T cells treated with Hs-MANF or Hs-MANF
(K112L) (purified from conditioned PBS of HEK293T-MANF::V5 cell lines) with or without sulfatide. b Exemplar western blot of lysates from target
HEK293T cells treated with Hs-MANF (purified from conditioned PBS of HEK293T-MANF::V5 cell lines) with increasing doses of sulfatide added to the
target HEK293T cell medium. c Exemplar immunofluorescence images of endogenous GPR78 (green) and V5-stained Hs-MANF (red), merged image with
DAPI after incubation with Hs-MANF (purified from conditioned PBS of HEK293T-MANF::V5 cell lines) and with V5 staining of no-sulfatide control. Arrow
heads indicate representative loci of co-localization. Scale bar, 20 µm
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and paracrine effects across tissues. In the mammalian nervous
system, sulfatide is present primarily on the extracellular leaflet of
the oligodendroglia-derived plasma membrane. However, sulfa-
tide is also present in extracellular matrix, blood serum, and on
the extracellular membrane leaflet of many other cell types. Thus,
it is conceivable that sulfatide as a lipid chaperone facilitates
MANF traveling across cells and also as a cell-surface lipid-type
receptor mediates the paracrine cytoprotection of MANF in vivo.
Aberrant levels and metabolism of sulfatide cause metachromatic
leukodystrophy characterized by severe neuropathy and are
associated with Parkinson’s disease, Alzheimer’s disease, cardio-
vascular disorders, and cancer24,35. The discovered physical
interaction between MANF and sulfatide as well as the functional
importance of their interaction for cytoprotection should help
understand their respective roles in physiology and therapeutic
potentials in many pathophysiological settings.
Methods
C. elegans strains and assays. C. elegans strains were cultured with standard
procedures unless otherwise specified. The N2 Bristol strain was used as the
reference wild-type strain, and the polymorphic Hawaiian strain CB4856 was used
for genetic mapping and SNP analysis36,37. Forward genetic screen for constitutive
GFP reporter-activating mutants after ethyl methanesulfonate (EMS)-induced
random mutagenesis was performed as described previously38,39. To generate
manf-1 null alleles in C. elegans, we used CRISPR-Cas9 to induce double-stranded
breaks and subsequent non-homologous end joining event caused various deletions
of the manf-1 gene and constitutive activation of hsp-4p::GFP. Feeding RNAi
starting from larval L1 stages was performed as previously described40. Transgenic
strains were generated by germline transformation as described41. Transgenic
constructs were co-injected (at 10–50 ng/μl) with unc-54p::mCherry, and lines of
mCherry+ animals were established. Strains used are as follows: zcIs4, manf-1
(dma1) IV; zcIs4 V, manf-1(tm3603) IV; zcIs4 V, manf-1(dma6) IV; zcIs4 V, manf-1
(dma7) IV; zcIs4 V, zcIs4 V, dyn-1(ky51) X; twk-18(cn110) X; dmaEx42[manf-1(+),
unc-54p::mCherry]; dmaEx28[manf-1p::Hs-MANF(+), unc-54p::mCherry];
dmaEx115[rpl-28p::manf-1::Venus], dmaIs4[manf-1p::GFP].
To examine effects of tunicamycin on progeny numbers and development, well-
fed L4 larvae were placed on the NGM plate containing 50 μg/ml of tunicamycin
for 1 or 24 h and then moved to fresh NGM plates without tunicamycin. Numbers
of viable progeny were counted in 24-h intervals. Five biological replicates (two
founders per plate) were used for statistical analysis.
Cell culture. HEK293T, H9C2, U2OS, and HeLa cell lines were initially purchased
from the American Type Culture Collection (ATCC, Manassas, VA, USA). The
cells were routinely cultured in Dulbecco’s modified Eagle's medium (DMEM)
supplemented with 10% (v/v) fetal bovine serum (FBS) and 1% penicillin/strep-
tomycin at 37 °C with 5% carbon dioxide. For in vitro cell model of H/R, oxygen-
glucose deprivation in 293T or H9c2 cells was induced by replacing the complete
high-glucose DMEM to glucose and serum-deprived medium in a hypoxia incu-
bator chamber (Nuaire) saturated with 99% nitrogen (modified from ref.42). After 5
or 16 h of hypoxia, the cells were cultured under no glucose condition and sub-
jected to reoxygenation under normoxia (21% O2) for 8 h.
MANF knockout HEK293T cells were generated using the CRISPR-Cas9
system as previously described43. Briefly, the online design tool (http://crispr.mit.
edu/) was used to select two high-score guide RNA (gRNA) target sites located at
first and the last exons containing a 20-base pair (bp) target sequence (targeting
sequences were GCGGTTCAGTCGGTCGGCGG and GTGCACGGACCGATT
TGTAG). Two pairs of 24- or 25-mer oligos for each guide were designed with BbsI
restriction enzyme cutting site. The oligos were annealed and phosphorylated, then
a
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Fig. 6 Sulfatide-bound MANF alleviates ER stress in mammalian cells. a Exemplar confocal GFP fluorescence images of Tg-induced stress granules in U2OS
cells pretreated with conditioned MANF in PBS or control PBS. Scale bar, 40 µm. b Quantification of the percentages of cells with granules induced by Tg in
60min and high doses (10 µl of conditioned medium/well) of Hs-MANF. A western blot for V5-tagged Hs-MANF indicates low and high doses of Hs-
MANF used for experiments in b and c. c Quantification of the percentages of cells with granules induced by Tg in 60min and low doses (2 µl of
conditioned medium/well) of Hs-MANF. Cells were deprived of serum for 48 h and then treated with conditioned PBS or MANF for overnight. Plots
represent quantification of the data from 10 images per condition from three independent experiments. Scale bar, 15 µm. *** indicates P < 0.001
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cloned into pSpCas9 (BB) plasmid (pX330) (Addgene plasmid ID 42230).
HEK293T cells were transiently transfected with two CRISPR/Cas9 construct
targeting MANF and puromycin expression construct. The next day, cells were
selected with puromycin for 2 days and subcloned to form single colonies. MANF
KO clones were identified by PCR screen. The obtained clones were validated by
qPCR and immunoblot using an antibody against MANF.
DNA constructs and lentiviral transfection. The pLX304-MANF and GAL3ST1
(also known as CST) plasmids were purchased from DNASU (Tempe, AZ, USA)
and the pLX304-MANF (K112L) was generated using Q5 site-directed mutagenesis
(New England Biolabs, Beverly, MA, USA). The tag-free pLX304-MANF was
generated using Q5 site-directed mutagenesis to remove the sequence encoding V5
tag. C. elegans constructs for transgenic strains were generated by direct PCR and
PCR fusions (plasmids and primers available upon request).
For lentiviral transfection, the plasmids with packaging plasmids were co-
transfected into HEK293FT (with a ratio of 2:1.5:1.5) using Turbofect reagent
(Thermo Fisher Scientific Inc. Waltham, MA, USA) according to the
manufacturer’s instructions. Lentivirus-containing medium was filtered from the
post-transfection supernatant and used for transduction of HEK293T cells. All
lentivirus-infected cells were cultured in the medium containing Polybrene (8 μg/
ml) from Sigma Aldrich (St. Louis, MO, USA). Forty-eight hours after
transduction, the cells were selected with 15 μg/ml Blastidicin S (Thermo Fisher
Scientific Inc., Waltham, MA, USA).
Purification MANF::v5 from conditioned medium. Stably MANF::V5-expressing
HEK293T cells were washed three times with PBS and incubated with PBS at 37 °C
for 4 h. The conditioned PBS was centrifuged at 2500 rpm for 10 min and filtered.
Then the conditioned PBS was concentrated using Amicon Ultra-15 10K cen-
trifugal filter devices for 100-fold concentration according to the manufacturer’s
instructions. For purification of MANF::V5 from conditioned PBS, the Anti-V5
affinity gel (Sigma Aldrich, St. Louis, MO, USA) was thoroughly suspended and 80
ul of the gel suspension was transferred to a fresh tube with addition of 1 ml of PBS
thoroughly suspended by pipetting followed by washing with PBS for four times.
Concentrated conditioned PBS was added to the washed resin and gently agitated
for 2 h at 4 °C. The resin was centrifuged for 30 s at 3000 rpm, washed with 1 ml
ice-cold PBS for five times. After the final wash, 100 μl of elution buffer (0.1 M
glycine HCl, pH 3.5) was added to each sample, which was incubated with gentle
shaking for 5 min at room temperature. The resin was centrifuged for 5 s at 8200 g
and the supernatants were immediately transferred to fresh tubes containing 10 μl
of 0.5 M Tris-HCl, pH 7.4, 1.5 M NaCl, to neutralize samples.
Immunoblot analysis. Laemmli loading buffer (Bio-Rad Lab, Hercules, CA, USA)
plus 5% β-mercaptoethanol was added to cell pellets or worm pellets before heating
at 95 °C for 5–15 min. Around 30 μg of whole cell protein lysate samples were
separated on mini-PROTEIN GTX precast gels, and transferred to nitrocellulose
membranes (Bio-rad Lab, Hercules, CA, USA). After blocking in TBS containing
5% non-fat milk and 0.1% Tween-20, the membranes were incubated overnight
with primary antibodies diluted in TBST (Tris buffered saline with Tween-20;
Genesee Scientific) with 5% milk at 4 °C, followed by incubation with secondary
antibodies at room temperature for 1 h. Immunoreactivity was visualized by the
ECL chemiluminescence system (Bio-rad). For MANF protein endocytosis-western
blot assay, HEK293T cells were plated at a density of approximately 100,000 cells
per well in a poly-L-ornithine-coated 24-well plates. Twenty-four hours after
plating, cells were starved in DMEM for 24 h before 3 h of anti-sulfatide antibody
(1:25) or sulfatase (20 μg/ml) treatment. Then, conditioned PBS with secreted Hs-
MANF was added to the cells for indicated times of duration. Internalization of Hs-
MANF were terminated by rapidly rinsing the cell three times with ice-cold PBS
and then lysing cells with 1× Laemmli sample buffer. The antibodies were V5
(ab3792, 1:2000; EMD Millipore Corporation, Darmstadt, Germany), HSP90 (sc-
13119, 1:5000; Santa Cruz Biotechnology, TX, USA), Tubulin (T5168, 1:10,000;
Cell signaling Sigma Aldrich, St. Louis, MO, USA, MA, USA), GFP (sc-9996,
1:50,001,000, Santa Cruz Biotechnology, TX, USA), His (6AT18, 1:20,003,000,
Sigma Aldrich (St. Louis, MO, USA), and Anti-O4 Antibody, clone 81, MAB345,
Millipore (1:100). Uncropped western blots of key experiments can be found in
Supplementary Figs 8 and 9.
Recombinant protein purification from E. coli. The plasmid pET-28a_Hs-MANF
or pET-28a_Ce-MANF (codons optimized for prokaryotic expression) was trans-
formed in E. coli BL21 pLysS cells and then grown at 37 °C in LB medium con-
taining 50 μg/ml kanamycin and to an absorbance at λ= 600 nm (A600). Protein
expression was induced with 0.5 mM IPTG and cells were grown 5 h at 37 °C (Hs-
MANF) or 16 h at 25 °C (Ce-MANF). Pelleted cells were resuspended in lysis buffer
(potassium phosphate buffer containing 1 mg/ml lysozyme, 0.02% Triton X-100,
PMSF 0.5 mM, protease inhibitor cocktail (Bimake, Houston, TX, USA), and lysed
by mild sonication. After cell debris removal by centrifugation, the solubilized
fraction was loaded onto a pre-equilibrated Ni2+-nitrilotriacetate column and
bound proteins were washed with washing buffer (100 mM potassium phosphate
buffer, pH 7.4, containing 60 mM imidazole). The purified protein was obtained
using elution buffer (potassium phosphate buffer (pH 7.4) containing 250 mM
imidazole.
Compound treatment. The compounds used in this study were as follows: pilipin
III (C35H58O11 ≥ 85%), Cytochalasin H (C30H39NO5 ≥ 95%), Coelenterazine-h
(C26H21N3O2 ≥ 95%), dynasore (C18H14N2O4 ≥ 95%), GW4869 (hydrochloride
hydrate, ≥95%), YM-201636 (C25H21N7O3 ≥ 95%), obtained from Cayman Che-
mical Company (Ann Arbor, Michigan, USA). Thapsigargin (C34H50O12, ≥95%)
and sulfatase (EC: 232-772-1) were purchased from Sigma Aldrich (St. Louis, MO,
USA). Sulfatides (C42H80NNaO11S, bovine source, ≥98%) were purchased from
Matreya LLC (State College,PA, USA). Cytochalasin H, pilipin III, Coelenterazine-
h, and dynasore were added 1 h before addition of conditioned PBS and remain
present in the medium. Sulfatide was added together with conditioned PBS and
kept in the medium. Cytochalasin H, pilipin III, Coelenterazine-h, and dynasore
were added 1 h before addition of conditioned PBS and kept in the medium.
Sulfatide were added together with conditioned PBS and kept in the medium.
Immunocytochemistry of C. elegans and mammalian cells. For immuno-
fluorescence staining of C. elegans, adult hermaphrodites were kept in control PBS
or MANF::V5 conditioned PBS with or without sulfatide (0.5 mM) overnight. The
animals were washed with M9 three times and fixed with 4% paraformaldehyde in
PBS for 30 min at room temperature. The animals were then washed three times in
PBS-Tween-20 (0.05% Tween-20 in PBS, pH 7.2) and incubated with 2% Tween-20
in PBS (PH 7.2) for 30 min at room temperature. The animals were rocked gently
overnight at 37 °C in 5% β-mercaptoethanol, 1% Triton X-100 in 0.125 M Tris-HCl
(pH 6.8). The animals were then washed and shaken vigorously in 0.4 ml of 100
mM Tris-HCl (pH 7.4), 1 mM CaCl2, and 2000 U/ml collagenase type IV (Sigma,
St. Lois, MO, USA). Once 20% of the animals were fragmented, the animals were
washed with PBS-Tween-20 and AbA solution (1% bovine serum albumin (BSA),
0.5% Triton X-100 in PBS), and rocked overnight at room temperature in 200 μl of
AbA solution containing V5 antibody (1:200) followed by additional incubation at
4 °C for 6 h. The animals were then washed three times in AbA solution and
incubated for 4 h at room temperature in the dark in 200 μl of ABA solution
containing Cy3-conjuated secondary antibody (1:200; EMD Millipore, Darmstadt,
Germany). The animals were washed with AbA solution, mounted on a slide, and
imaged by Leica (Wetzlar, Germany) confocal fluorescence microscopy.
For immunocytochemistry of mammalian cells, HEK293T cells were seeded on
coverslips within 24-well plates and 24 h later, the cells were treated with Hs-
MANF::V5 PBS or equivalent amount of HEK293T PBS for 24 h. The cells were
fixed with 4% paraformaldehyde in PBS, washed with PBS, and permeabilized with
0.02% Triton X-100 in PBS for 10 min. Blocking was done with 5% BSA in PBS for
1 h, followed by incubation with antibodies against V5 (1:400), GRP78 (1:250) in
blocking buffer overnight at 4 °C. The mouse antibodies were detected using goat
anti-mouse Alexa 488 (1:1000; Jackson ImmunoResearch Laboratories Inc.) and
the rabbit antibody was detected using Cy3-conjuated donkey anti-rabbit (1:500;
EMD Millipore) and goat anti-mouse in blocking buffer. Cells were extensively
washed with PBS after primary and secondary antibody staining. Stained cells were
overlaid with Fluoroshield mounting medium with DAPI (Abcam) to label nucleus.
Fluorescence microscopy was performed with a Leica confocal microscope using
the following fluorescence filters: DAPI (405 nm excitation for nuclear); Cy3 (551
nm excitation) for V5 staining; and GFP (488 nm excitation). For comparison
across conditions, identical light-exposure levels were used.
Granule quantification. The GFP-G3BP-marked U2OS cells were plated at a cell
density of approximately 50,000 in 24-well plate. Twenty-four hours later, the
medium was changed to serum-free DMEM to starve for 48 h. Conditioned PBS or
MANF-containing medium was added to the cells 16 h before changing to medium
containing 0.5 μM Thapsigargin for 40 h to induce granules. Granules were
visualized by an upright laser-scanning confocal microscope (Leica SPE) for
imaging and by an EVOS FL Auto 2 Cell Imaging System (Thermo Fisher Scientific
Inc.) for quantification with 10 fields per time point. Magnification of ×20 was used
for the analysis of the percentage of cells with granules. With ImageJ 1.48v (Wayne
Rasband), the number of cells with granules and total cells per field were counted.
Each microscopic field contains around 100 cells at 60% confluency. Percentages of
cells with at least one granule with granules were quantified under the same criteria
for the indicated sets of thapsigargin, MANF, and sulfatide treatments.
Lipid protein overlay binding assay. Echelon lipid overlay assay using the
Sphingo strip (Catalog No.: S-6000) was performed according to the manu-
facturer’s instruction (Echelon Biosciences Inc). For customized lipid overlay
assays, sulfatide was dissolved in chloroform/methanol (1:1) at the concentration of
10 nm/μl. One microliter of the lipids was spotted onto a nitrocellulose membrane
at the 1:1, 1:2, 1:4, 1:8, 1:16, 1:32, 1:64, 1:128 dilutions. The membrane was then
subsequently air-dried, blocked with 3% protease-free BSA in Tris-buffered saline
with 0.1% Tween (TBST) for 1 h, overlaid with His::MANF protein (0.5 μg/ml in
blocking buffer) or Hs-MANF::V5 conditioned medium (1 ml conditioned medium
mixed with 2 ml blocking buffer) for 1 h. After three washes with TBST, the
membrane was incubated with indicated primary antibodies for 1 h or overnight at
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4 °C, followed by three washes with TBST and incubating the membrane with
secondary antibodies for chemiluminescence imaging.
Validated antibodies for sulfatide lipid overlay assay include anti-V5 (ab3792,
dilution 1:1000; Abcam), anti-His (6AT18, 1:1000; Sigma), anti-MANF C-terminus
(ab67271, dilution 1:1000; Abcam). The antibody targeting the N-terminal
Saposin-like domain of MANF (ab129602, dilution 1:1000; Abcam) did not work
in the sulfatide lipid overlay assay likely because of its competing with sulfatide for
the same epitope. Lipids used for the lipid overlay assay include: Sulfatides (13135
and 860572, Avanti Polar Lipids; 1049, Matreya), Cerebrosides (131303 and
131304, Avanti Polar Lipids), lyso-Sulfatide (1904, Matreya), N-Dodecanoyl-NBD-
sulfatide (1632, Matreya), psychosine (P9256, Sigma)
Cell death assay. HEK293T cells were plated in 24-well plates at a density of
approximately 100,000 per each well. After 12 h of cell attachment, 10 μl con-
centrated PBS containing secreted Hs-MANF or Hs-MANF (K112L) in the pre-
sence or absence of sulfatide (100 μM) were added to the cells, while equal volumes
of dimethyl sulfoxide were used as vehicle controls. Sixteen hours later, the cells
were treated with thapsigargin (1.5 μM) for 40 h. For anti-sulfatide antibody or
sulfatase pretreatment, anti-sulfatide antibody O4 (Millipore) and sulfatase (Sigma
Aldrich) were added 3 h prior to MANF PBS addition. Both detached and floating
cells were collected by centrifugation and washed with 1 ml PBS. The collected cells
were resuspended with 300 μl PBS with addition of 0.3 μl Sytox blue (1 μM;
Thermo Fisher) for an additional 5 min. The fluorescence intensity was measured
for individual HEK293T cells using flow cytometry 20 min after staining, and the
percentage of cell deaths was quantified using the Flowjo software.
Sulfatide quantification in biological samples. Cells were homogenized by
sonication in MilliQ water. Total lipid fraction was obtained by Folch extraction in
chloroform/methanol (2/1, v/v) mixture containing 50 ng of C12:0 sulfatide
internal standard. The organic and water phases were separated by centrifugation
at 14,000 × g for 5 min. The lower organic phase was transferred to a glass vial and
dried under stream of nitrogen (3×). Then the residue was dissolved in 500 μl of
methanol prior to tandem mass-spec analysis. Mass spectra were measured on an
AB/MDS ABI/MDS SCIEX API 4000 triple quadrupole tandem mass spectrometer
equipped with an ESI source and coupled to an Agilent HPLC 1290 series. Samples
were electrosprayed in the negative ion mode to form [M–H]− ions. Generated ions
were analyzed by SRM of precursor ions and the common HSO4− (m/z 97)
fragment ion. Data were processed using Analyst 1.6 software.
Biochemical and biophysical analysis of recombinant MANF. Purified Hs-
MANF was dissolved in 50 mM sodium phosphate (pH 7.4) containing 100 mM
NaCl, 0.05% Tween-20, and different doses of sulfatide. Samples were analyzed
using a Superdex 75 10/300 GL column when 200 μl of Hs-MANF protein samples
(0.5 mg/ml) was injected. For limited proteolysis the protein samples (0.5 mg/ml)
with the ligand were digested by trypsin (MANF-trypsin (w/w) ratio of 1000-1). At
the chosen time point, proteolysis was quenched in 0.5% TFA. Cleaved proteins
were analyzed by silver-stained SDS-PAGE. For differential scanning fluorimetry,
Hs-MANF (0.5 mg/ml) was dissolved in 50 mM sodium phosphate (pH 7.4)
containing 100 mM NaCl. To analyze the effect of sulfatide on protein thermo-
stability, the proteins were incubated with the ligand in defined concentration for
10 min at room temperature prior to measurement. Using a Prometheus NT.48
(NanoTemper), the proteins were heated from 20 to 90 °C, and tryptophan-based
fluorescence was recorded.
Statistical analysis. Data were analyzed using GraphPad Prism Software
(Graphpad, San Diego, CA) and presented as means ± S.E. unless otherwise spe-
cified, with P-values calculated by two-tailed unpaired Student’s t-tests or two-way
ANOVA (comparisons across more than two groups) adjusted with the Bonfer-
roni’s correction. No randomization or blinding was used and no power calcula-
tions were done to detect a pre-specified effect size.
Data availability. The data that support the findings of this study are available
from the corresponding author upon reasonable request.
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